Argenx
ARGX
#422
Rank
ยฃ43.55 B
Marketcap
ยฃ692.57
Share price
3.63%
Change (1 day)
4.73%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -ยฃ3.35

According to Argenx 's latest financial reports the company's current EPS (TTM) is ยฃ16.70. In 2022 the company made an earnings per share (EPS) of -ยฃ9.80.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ3.35-65.77%
2022-ยฃ9.80